| 000 | 01709 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518083704.0 | ||
| 264 | 0 | _c20201120 | |
| 008 | 202011s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/s41598-020-58690-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKatende, Bulemba | |
| 245 | 0 | 0 |
_aRifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes. _h[electronic resource] |
| 260 |
_bScientific reports _c02 2020 |
||
| 300 |
_a1917 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibiotics, Antitubercular _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluoroquinolones _xpharmacology |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLesotho _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xstandards |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 |
_aSputum _xmicrobiology |
| 650 | 0 | 4 |
_aTime-to-Treatment _xstandards |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdiagnosis |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdiagnosis |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aEsterhuizen, Tonya M | |
| 700 | 1 | _aDippenaar, Anzaan | |
| 700 | 1 | _aWarren, Robin M | |
| 773 | 0 |
_tScientific reports _gvol. 10 _gno. 1 _gp. 1917 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-020-58690-4 _zAvailable from publisher's website |
| 999 |
_c30601888 _d30601888 |
||